Empower Your Staff. Educate Your Patients.
Clinical education resources for practitioners and their teams. Everything you need to confidently introduce Kannaco topicals into your practice — from staff training scripts to patient-ready handouts.
Staff Training
Train Your Team to Recommend with Confidence
Front desk staff and clinical assistants are often the first point of contact when patients ask about CBD. These four training steps give your entire team the knowledge and language to answer questions accurately and professionally.
Product Knowledge Basics
Ensure every team member understands the difference between full-spectrum and isolate formulas, the three Kannaco products, and which patients each is appropriate for.
Patient Communication Scripts
Provide word-for-word language for introducing CBD to patients, addressing skepticism, and explaining the products in non-clinical terms.
Drug Test & Compliance FAQs
Train staff to confidently answer drug test questions and know when to refer to the practitioner for more detailed clinical discussion.
Handling Objections
Prepare your team for common patient concerns: cost, skepticism about CBD, medication interactions, and prior negative experiences.
Training Modules
Available for your entire team
CBD Basics for Non-Clinical Staff
What CBD is, what it isn't, and how to explain it simply to patients who have never tried it.
Patient Communication Essentials
Word-for-word scripts for introducing products, handling objections, and answering the most common questions.
Compliance & Documentation
Drug test safety, FDA copy rules, and how to document product recommendations in patient records.
Patient Communication
Scripts and Language That Work
FDA-compliant language and proven communication frameworks for the most common patient conversations about CBD topicals.
Introducing CBD for the First Time
What to say
"We carry a line of topical hemp-derived products that many of our patients have found helpful for post-treatment recovery and general discomfort. They're applied directly to the skin, so they don't enter your bloodstream. Would you like to learn more?"
What to avoid
- Saying it "treats" or "heals" any condition
- Comparing it to marijuana or recreational cannabis
Addressing Drug Test Concerns
What to say
"Our Pro Cream and Pro Roll-On use CBD and CBG isolate — they contain zero THC, which is verified by a third-party lab on every batch. We can provide the Certificate of Analysis if you'd like documentation. For patients with strict zero-tolerance policies, I'd recommend consulting your compliance officer as well."
What to avoid
- Guaranteeing a patient will pass a drug test
- Recommending the Cooling Cream (full-spectrum) to drug-tested patients
Explaining Full Spectrum vs. Isolate
What to say
"Full spectrum means the product contains all the naturally occurring compounds from the hemp plant — including a trace amount of THC under the federal limit. Our Pro formulas use isolate, which means only the specific cannabinoids we selected, with all others removed. Both are effective; the choice depends on your preferences and whether you're subject to drug testing."
What to avoid
- Saying one is "better" than the other without context
- Overpromising on the entourage effect as a guaranteed benefit
Patient Education Materials
Ready-to-Use Materials for Your Practice
FDA-compliant, print-ready resources designed for practitioner distribution. Request any materials through your Kannaco account representative.
Product Comparison One-Pager
Side-by-side comparison of all three Kannaco topicals — cannabinoid profiles, THC content, sensory experience, and best-use scenarios. Ideal for patient consultation.
PDF — Print ReadyHow CBD Topicals Work
Patient-friendly explanation of the endocannabinoid system, peripheral receptors, and how topical application works — without entering the bloodstream. Written at a 6th-grade reading level.
PDF — Print ReadyDrug Test Safety Guide
Explains the difference between full-spectrum and isolate formulas, includes SC Labs COA summary, and provides guidance for patients subject to drug testing. Includes a copy of the 0.0% THC verification.
PDF — Print ReadyHome Use Protocol
Step-by-step application guide for patients using Kannaco topicals at home. Covers application frequency, technique, skin preparation, and what to expect in the first 2 weeks of consistent use.
PDF — Print ReadyFrequently Asked Questions
Staff & Patient Education FAQ
Common questions from practitioners building education programs for their teams and patients.
Kannaco provides a comprehensive staff training guide covering product knowledge, patient communication scripts, drug test and compliance FAQs, and objection handling. The guide is available in PDF format and is designed for both clinical and non-clinical team members. Contact your account representative to request the full training package.
Focus on the mechanism rather than the compound. Explain that the products interact with receptors in the skin and underlying tissue — the same receptors involved in the body's natural recovery process. Emphasize that the products are third-party tested, hemp-derived, and federally legal. Avoid making treatment claims
Yes. Kannaco provides four print-ready patient education materials: a Product Comparison One-Pager, a How CBD Topicals Work guide, a Drug Test Safety Guide, and a Home Use Protocol. All materials are FDA-compliant. Contact your account representative to request print-ready PDF versions or inquire about co-branded options.
Use 'discomfort' instead of 'pain.' Use 'support recovery' instead of 'treat' or 'heal.' Describe the products as 'hemp-derived' rather than 'marijuana-derived.' Never claim the products diagnose, treat, cure, or prevent any disease or condition. Stick to structure/function language: 'formulated to support post-activity recovery' is compliant
Direct them to the Pro Cream or Pro Roll-On — both contain 0.0% THC, verified by SC Labs on every batch. Provide the Certificate of Analysis as documentation. Explain that topical application does not produce blood levels detectable by standard urine drug screens. For patients with strict zero-tolerance policies, recommend consulting their compliance officer before use.
Yes, with attribution. Kannaco educational content may be shared on practitioner websites and social media with a link back to kannacocbd.com. Do not modify the content in ways that add medical claims. For social media, follow FTC guidelines and disclose your practitioner relationship with Kannaco. Contact your rep for co-branded content options.
CBD (cannabidiol) is the primary non-psychoactive cannabinoid in hemp, known for its interaction with peripheral CB1 and CB2 receptors. CBG (cannabigerol) is a precursor cannabinoid that also interacts with CB2 receptors and is associated with anti-inflammatory properties. THC (tetrahydrocannabinol) is the psychoactive compound in cannabis
Use this analogy: full-spectrum is like whole fruit — it contains all the naturally occurring compounds from the hemp plant, including trace THC. Isolate is like a specific vitamin extracted from that fruit — only the targeted compounds remain. Both are effective
Train front desk staff to use this response: 'We carry a line of hemp-derived topical products that many of our patients use for post-treatment recovery and general discomfort. They're applied directly to the skin and don't enter your bloodstream. Would you like me to have the doctor or therapist tell you more about them?' This is informative, non-clinical, and compliant.
Yes. The Kannaco Clinical Quick Reference is a one-page laminated guide covering all three products, their cannabinoid profiles, recommended use cases, drug test status, and key communication points. It's designed to be kept at the treatment table or front desk. Contact your account representative to request a copy.